首頁 > 市場調查報告書 > 醫療設備

病患監測泌尿科

市場調查報告書

商品編碼

1439323

全球尿力學設備市場：洞察、競爭格局、市場預測：2030 年

Urodynamic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球尿動力器材市場規模為4.0335億美元。預計到 2030 年，該市場將達到 5.7316 億美元，2024 年至 2030 年的預測期內複合年增長率為 6.03%。由於腎臟疾病盛行率上升、膀胱癌盛行率上升、尿動力學設備的技術進步等，預計尿動力學設備市場將在2024年至2030年的預測期內成長，進而促進市場成長。

腎臟疾病盛行率的上升是尿動力學設備市場的主要驅動因素。

例如，根據2020年世界腎臟日組織的說法，腎臟疾病是一種非傳染性疾病，影響全球約8.5億人。據同一消息來源稱，據觀察，大約十分之一的成年人患有慢性腎病，預計到 2040 年，慢性腎臟病將成為全球第五大常見死亡原因。

根據美國國家腎臟基金會（National Kidney Foundation） 2022 年的公告，到 2020 年，世界上大約 10% 的人口將受到慢性腎臟病的影響，由於無法獲得負擔得起的治療，每年將有數千人患有慢性腎臟病。同一數據顯示，2020年有超過200萬人接受透析或腎臟移植治療，但這一數字僅佔需要治療才能生存的人的10%。

根據美國疾病管制與預防中心2022（Centers for Disease Control and Prevention 2022）預測，預計到2020年，美國每7個人中就有超過1人，即15%，即3,700萬人，將患有慢性腎臟病。

據英國腎臟護理協會Kidney Care UK稱，2020 年英國約有 300 萬人患有慢性腎臟病。據同一消息來源稱，英國每年約有 40-45,000 人因 CKD 過早死亡。

因此，腎臟疾病盛行率的上升預計將增加對尿動力學設備的需求並推動尿動力學設備市場的成長。

該報告研究了全球尿動力學設備市場，並提供了市場概述，包括按產品類型、最終用戶、地區和參與市場的公司概況劃分的趨勢。

B Braun Meslungen AG
BestMedical
MINZE HEALTH
Santron Meditronic.
Potent Medical
Laborie
MEDKONSULT medical technology s.r.o.
The Prometheus GroupR
HCItalia srl
DeltaMed
Aymed Medical Technology
EV.SERVICE ITALIA
tic Medizintechnik GmbH & Co. KG
Creo Medical Ltd
Stericom Ltd.
Amecath Medical Technologies
Cook
Well Lead Medical Co., Ltd
MEDICA S.P.A

第10章 KOL觀點

第十一章專案方法

第 12 章. 關於 DelveInsight

第十三章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0115

Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps And Transducer Sets, Others), By End-User (Hospitals And Urology Clinics, Ambulatory Surgery Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of kidney disorders, increasing prevalence of bladder cancers

Global Urodynamic Devices Market was valued at USD 403.35 Million in 2023, growing at a CAGR of 6.03% during the forecast period from 2024 to 2030 to reach USD 573. 16 Million by 2030. The Urodynamic Devices market is witnessing positive growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2024-2030.

Urodynamic Devices Market Dynamics:

The rising prevalence of kidney disorders is the key driving factor for the Urodynamic Devices market.

For instance, as per the World Kidney Day organization in 2020, kidney disease is a non-communicable disease affecting about 850 million people across the world. as per the same source, about one in ten adults are observed to be suffering from chronic kidney disease which is projected to become the fifth most common cause of life loss globally by the year 2040.

As per the National Kidney Foundation 2022, in 2020 about 10% of the population globally suffered from chronic kidney diseases and millions of people were dying every year as they did not have enough access to affordable treatments. As per the same source, about over 2 million people had received treatment with dialysis or kidney transplant in the year 2020 but this number represents only 10% of the people requiring treatment to stay alive.

According to the Centers for Disease Control and Prevention 2022, more than one in seven, that is 15% of the US people or 37 million people were estimated to be have suffered from chronic kidney disorders in the year 2020.

As per the Kidney Care UK in 2020, around 3 million people in the United Kingdom were suffering from chronic kidney diseases. Also as per the same source, there are about 40-45,000 premature deaths in the UK every year due to CKD.

Therefore, due to the rising prevalence of kidney disorders, there will be an increase in the demand for urodynamic devices, thereby fueling the market growth for Urodynamic Devices.

However, the high cost of the urodynamic devices and tests and complications associated with urodynamic catheters such as pain, patient anxiety, and injury may be certain limiting factors of the Urodynamic Devices market growth.

The unprecedented COVID-19 outbreak had a profound impact on the market for urodynamic devices. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patients visits, and all other surgical/diagnostic procedures were temporarily paused, giving more attention to the COVID-19 inflicted patients. However, as a result of relaxation observed in the COVID-19 lockdown and the approvals and launches in the urodynamic devices arena, there had been normalcy attained in the growth of the urodynamic devices market.

Urodynamic Devices Market Segment Analysis:

Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps and Transducer Sets, Others), By End-User (Hospitals and Urology Clinics, Ambulatory Surgery Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product Type segment of the Urodynamic Devices market, Electromyograph are estimated to hold a higher share in the Urodynamic Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.

The demand for electromyography devices will improve owing to the rising prevalence of kidney disorders and bladder cancers globally, the approval and launch of electromyography devices, and the increased research and development on electromyography devices.

For instance, as per the World Bladder Cancer Patient Coalition in the year 2020, about 573,278 people are suffering from bladder cancer globally. As per the same source, bladder cancer is considered the tenth most commonly diagnosed cancer in the world.

As per the National Institute of Health in the year 2020, the rate of new cases of bladder cancer was 19.7 per 100,000 men and women per year. As per the same source, approximately 2.4 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2016-2018 data.

Furthermore, according to the International Society of Nephrology 2022, in the year 2020 more than 850 million people were suffering from chronic kidney disorders.

Hence, all the aforementioned factors will contribute to the growth of electromyograph devices in Urodynamic Devices market.

North America is expected to dominate the overall Urodynamic Devices Market:

Among all the regions, North America is expected to account for the largest share in the Global Urodynamic Devices market. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country.

According to the National Institute of Health in the year 2020, 1 in 7 adults in the United States was suffering from chronic kidney disease. This accounts for a total of 37 million Americans.

Also, as per the Centers for Disease Control and Prevention 2022, in the year 2020 chronic kidney disorders are more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) for the United States.

As per the American Journal of Kidney Diseases 2020, End-Stage Renal Disease (ESRD) prevalence in the United States remains one of the highest in the world at 2,242 cases per million population in 2018.

As per the American Cancer Society's estimates for bladder cancer in the United States in the year 2020, about 83,730 new cases of bladder cancer were diagnosed (about 64,280 in men and 19,450 in women).

Thus, all the above-mentioned factors are anticipated to propel the market for Urodynamic Devices in the United States region.

Urodynamic Devices Market Key Players:

Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.

Recent Developmental Activities in the Urodynamic Devices Market:

In March 2022, A video urodynamic lab was inaugurated at the Delhi government-run Lok Nayak Hospital by Health Minister. The lab is capable of taking real-time pictures of the urinary tract and bladder, which also provides immediate biofeedback.

Key Takeaways from the Urodynamic Devices Market Report Study

Market size analysis for current Urodynamic Devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urodynamic Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global Urodynamic Devices market.
Various opportunities available for the other competitor in the Urodynamic Devices market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current Urodynamic Devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Urodynamic Devices market growth in the coming future?

Target Audience who can be benefited from this Urodynamic Devices Market Report Study

Urodynamic Devices products providers
Research organizations and consulting companies
Urodynamic Devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Urodynamic Devices
Various End-users who want to know more about the Urodynamic Devices market and latest technological developments in the Urodynamic Devices market.

Frequently Asked Questions for the Urodynamic Devices Market:

1. What are Urodynamic Devices?

Urodynamic Devices are created to investigate the function of the urinary tract by taking physical measurements of bladder pressure and flow rates.

2. What is the market for Global Urodynamic Devices?

Global Urodynamic Devices Market was valued at USD 403.35 Million in 2023, growing at a CAGR of 6.03% during the forecast period from 2024 to 2030 to reach USD 573. 16 Million by 2030.

3. What are the drivers for the Global Urodynamic Devices Market?

The Urodynamic Devices market is witnessing positive market growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2024-2030

4. Who are the key players operating in the Global Urodynamic Devices Market?

5. Which region has the highest share in Urodynamic Devices Market?

North America is expected to hold the highest share in the revenue in the Urodynamic Devices market during the forecast period. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along with favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country are expected to aid in the growth of the North America Urodynamic Devices Market.

1.Urodynamic Devices Market Report Introduction

2.Urodynamic Devices Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Urodynamic Devices Market Key Factors Analysis

4.1. Urodynamic Devices Market Drivers
- 4.1.1. Rising Prevalence of Kidney Disorders
- 4.1.2. Increasing Prevalence of Bladder Cancers
- 4.1.3. Technological Advancements in Urodynamic Equipment
4.2. Urodynamic Devices Market Restraints and Challenges
- 4.2.1. High Cost of the urodynamic devices and tests
- 4.2.2. Complications associated with urodynamic catheters such as pain, patient anxiety, and injury
4.3. Urodynamic Devices Market Opportunities
- 4.3.1. Growing cases of urinary incontinence globally
- 4.3.2. A shift from invasive to non-invasive forms of urodynamic testing procedures

5. Urodynamic Devices Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Urodynamic Devices Market

7. Urodynamic Devices Market Layout

7.1. By Product Type
- 7.1.1. Uroflowmetry Equipment
- 7.1.2. Electromyograph
- 7.1.3. Urodynamic Systems
- 7.1.4. Urodynamic Catheters
- 7.1.5. Urodynamic Pumps and Transducer Sets
- 7.1.6. Others
7.2. By End-User
- 7.2.1. Hospitals and Urology Clinics
- 7.2.2. Ambulatory Centres
- 7.2.3. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. North America Urodynamic Devices Market, by Country
  - 7.3.1.1.1. United States
  - 7.3.1.1.2. Canada
  - 7.3.1.1.3. Mexico
- 7.3.2. Europe
  - 7.3.2.1. Europe Urodynamic Devices Market, by Country
  - 7.3.2.1.1. France
  - 7.3.2.1.2. Germany
  - 7.3.2.1.3. United Kingdom
  - 7.3.2.1.4. Italy
  - 7.3.2.1.5. Spain
  - 7.3.2.1.6. Russia
  - 7.3.2.1.7. Rest of Europe
- 7.3.3. Asia-Pacific
  - 7.3.3.1. Asia-Pacific Urodynamic Devices Market, by Country
  - 7.3.3.1.1. China
  - 7.3.3.1.2. Japan
  - 7.3.3.1.3. India
  - 7.3.3.1.4. Australia
  - 7.3.3.1.5. South Korea
  - 7.3.3.1.6. Rest of Asia Pacific
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. RoW Urodynamic Devices Market, by Country
  - 7.3.4.1.1. Middle East
  - 7.3.4.1.2. Africa
  - 7.3.4.1.3. South America

8. Urodynamic Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Urodynamic Devices Market Company and Product Profiles

9.1. B Braun Meslungen AG
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. BestMedical
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. MINZE HEALTH
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Santron Meditronic.
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. Potent Medical
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Laborie
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. MEDKONSULT medical technology s.r.o.
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. The Prometheus Group®
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. HCItalia srl
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. DeltaMed
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. Aymed Medical Technology
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. EV.SERVICE ITALIA
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. tic Medizintechnik GmbH & Co. KG
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Creo Medical Ltd
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. Stericom Ltd.
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Amecath Medical Technologies
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Cook
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. Well Lead Medical Co., Ltd
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. MEDICA S.P.A
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy